liberty media corp-liberty live glp-1 receptor agonist medications involvement Dr. Anjana and I are quoted in today's The Hindu on WHO's inclusion of drugs in the Essential Medicines List — a landmark move for affordable and accessible diabetes care Glucagon-like peptide 1 receptor agonists:

As federal regulators intensify scrutiny of compounded GLP-1 drugs and telehealth marketing practices, two developments in early March 2026 signal a turning point for the industry: a wave of FDA enforcement actions and a high-profile resolution between Hims & Hers Health and Novo Nordisk

Is it just tirzepatide ( Mounjaro )

Pseudo-Bartter syndrome without hypopotassemia: a case with unilateral multicystic dysplastic kidney and congenital contralateral hyronephrosis

A recent meta-analysis of 157 randomized controlled trials (RCTs) indicated that dipeptidyl peptidase-4 inhibitors do not affect overall cancer risk and are associated with a significantly reduced risk of colorectal cancer [6]

Wegovy's starting dose (0.25 mg) is a true "priming" dose with minimal therapeutic effect